The Heart Outcomes in Pregnancy Expectations for Mom and Baby Study

NCT06517628 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2025-01-20

No results posted yet for this study

Summary

This is a prospective, observational study which is evaluating the obstetrical, neonatal, and cardiovascular outcomes of 1000 pregnant people with known heart disease to define how best to structure cardio-obstetrics care to optimize outcomes.

Conditions

  • Pregnancy Complications, Cardiovascular

Interventions

OTHER

Purely observational study on the care and outcomes of participants with cardiovascular disease in pregnancy.

The primary exposure variable is the organization of cardio-obstetrics care which will be defined by annual site surveys and its association with outcomes will be defined by hierarchical models adjusting for patient characteristics.

Sponsors & Collaborators

  • Albert Einstein College of Medicine

    collaborator OTHER
  • Baylor College of Medicine

    collaborator OTHER
  • Beth Israel Deaconess Medical Center, Inc.

    collaborator UNKNOWN
  • The Children's Hospital Corporation

    collaborator UNKNOWN
  • The Brigham and Women's Hospital, Inc.

    collaborator UNKNOWN
  • The Trustees of Columbia University in the City of New York

    collaborator UNKNOWN
  • Henry Ford Hospital

    collaborator OTHER
  • The Johns Hopkins University

    collaborator UNKNOWN
  • The Miriam Hospital/Lifespan

    collaborator UNKNOWN
  • The General Hospital Corporation d/b/a Massachusetts General Hospital

    collaborator UNKNOWN
  • Northwell Health

    collaborator OTHER
  • Northwestern University

    collaborator OTHER
  • Oregon Health and Science University

    collaborator OTHER
  • Saint Luke's Health System Inc.

    collaborator UNKNOWN
  • Board of Trustees of the Leland Stanford Junior University

    collaborator UNKNOWN
  • The Research Foundation for the State University of New York

    collaborator UNKNOWN
  • The Regents of the University of California, Irvine

    collaborator UNKNOWN
  • The Regents of the University of California, Los Angeles

    collaborator UNKNOWN
  • University of North Carolina, Chapel Hill

    collaborator OTHER
  • The Board of Trustees of the University of Illinois

    collaborator UNKNOWN
  • Trustees of Indiana University

    collaborator UNKNOWN
  • University of Kansas Medical Center

    collaborator OTHER
  • University of Massachusetts Chan Medical School

    collaborator UNKNOWN
  • Regents of the University of Michigan

    collaborator UNKNOWN
  • University of Mississippi Medical Center

    collaborator OTHER
  • The Curators of the University of Missouri

    collaborator UNKNOWN
  • The Trustees of the University of Pennsylvania

    collaborator UNKNOWN
  • University of Pittsburgh

    collaborator OTHER
  • The University of South Florida Board of Trustees for University of South Florida

    collaborator UNKNOWN
  • University of Washington

    collaborator OTHER
  • UT Southwestern Medical Center

    collaborator UNKNOWN
  • Weil Medical Colleqe of Cornell University

    collaborator UNKNOWN
  • Women and Infants Hospital of Rhode Island

    collaborator OTHER
  • Tennessee Maternal Fetal Medicine PLC

    collaborator UNKNOWN
  • University of Missouri, Kansas City

    lead OTHER

Principal Investigators

  • John Spertus, MD, MPH · University of Missouri, Kansas City

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-14
Primary Completion
2028-06-30
Completion
2028-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06517628 on ClinicalTrials.gov